SLAS2024 Ignite Theater: Will you be there?

Boston, MA

Make sure you leave time in your SLAS2024 schedule to attend the Ignite Theater track on the theme ‘Innovation & technology: from lab to patient’.

The programme, curated by DDW and sponsored by Integra Biosciences and Hamamatsu Corporation, will feature leading research from experts in academia, government agencies and industry on how technology is innovating from bench to bedside.

What you will learn:

  • How advances in technology have accelerated drug development
  • How AI can address key bottlenecks in the drug discovery process
  • Which technological advancements are likely to have the greatest impact
  • The role of new technology in the post-launch phase
  • How technology is enabling quicker and more comprehensive characterisation of vaccine candidates
  • The role of cutting-edge technologies like patient-on-a-chip, real-time nano-sensing and stem cell genomic diversity

The presentations will include:

Monday 5 February

11.30am: Is pharma’s commercial model dying? How data is enabling new insights and why it’s better for the patient, by Dipanwita Das, CEO, Sorcero

3pm: Combining physics-based methods with AI to maximise the success and speed of drug discovery and development, by Andrea Bortolato, Director of Drug Discovery, SandboxAQ

3.30pm: Proximity-inducing drugs: using technological innovation to build the next generation of medicine, by Simon Bushell, SVP of Molecular Discovery, Entact Bio

Tuesday 6 February

11.30am: Structural vaccinology for influenza: The technology behind the NIAID Vaccine Research Center’s (VRC) nanoparticle-based vaccines, by Masaru Kanekiyo, DVM, PhD Chief of Molecular Immunoengineering Section of the Vaccine Research Center (VRC) in NIAID

3pm: How AI and Patient-on-Chip are improving drug development, by Isaac Bentwich, CEO, Quris AI

3.30pm: Accelerating biotherapeutics development through technology platforms, by Anubhav Tripathi, Professor of Medical Science and Engineering at Brown University

Register now to show your interest.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free